ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Turk J Vasc Surg. 2025; 34(3): 204-211


Long-term survival, amputation and graft-related complications following femoropopliteal bypass surgery

İsa Bolat, Uğur Karagöz, Tünay Kurtoğlu.



Abstract
Download PDF Post

Background: Peripheral arterial disease (PAD) is caused by atherosclerosis and affects the lower extremity arteries. Surgical methods including infrainguinal bypass play an indispensable role in the treatment of PAD. We aimed to investigate the long-term outcomes of femoropopliteal bypass surgery primarily focusing on survival, amputation and graft related complications (thrombosis and graft infection).
Material and Methods: A total of 77 patients who underwent isolated femoropopliteal bypass surgery between January 2015 and January 2022 were retrospectively analyzed. Clinical characteristics and demographic data of the patients, preoperative and postoperative Rutherford categories were noted. Amputation, survival, and graft-related complication rates were reviewed.
Results: During the follow-up period (average of seven years), the overall mortality was 44.2%. Overall survival rates were observed to be lower in patients with chronic renal failure (p

Key words: Femoropopliteal bypass, risk factors, graft failure





Bibliomed Article Statistics

9
9
R
E
A
D
S

6

5
D
O
W
N
L
O
A
D
S
1112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.